Results 241 to 250 of about 448,489 (363)

Blockade of cannabinoid CB1 receptors potentiates the anti‐fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy

British Journal of Pharmacology, Volume 182, Issue 21, Page 5355-5377, November 2025.
Background and purpose Diabetic nephropathy (DN) is a common complication of diabetes. Current treatments include renin‐angiotensin‐aldosterone system (RAAS) blockers and sodium‐glucose co‐transporter 2 (SGLT2) inhibitors. The cannabinoid CB1 receptor is a potential therapeutic target.
Océane Pointeau, Awa Isma Ba, Audrey Geissler, Romain Barbosa, Abhishek Basu, Arif Muhammad, Marina Nivot, Maéva Loriot, Julia Leemput, Patricia Passilly‐Degrace, Sébastien Causse, Laurent Demizieux, Hélène François, Bruno Vergès, Jianmin Duan, Geneviève Gaucher, Michael Harvey, Pascal Degrace, Glenn Crater, Resat Cinar, Tony Jourdan   +20 more
wiley   +1 more source

Diagnostic Value of Sirtuin-1 in Predicting Contrast-Induced Nephropathy After Percutaneous Coronary Intervention. [PDF]

J Clin Med
Ardic M, Gul CB.
europepmc   +1 more source

Nephrogenic systemic fibrosis and contrast medium-induced nephropathy: a choice between the devil and the deep blue sea for patients with reduced renal function?

, 2009
Karen Lind Gandrup, Henrik S. Thomsen
openalex   +1 more source

Contrast-induced nephropathy in ITU patients: outcomes of a university hospital re-audit [PDF]

, 2011
K Lam, Tak Mao Chan, Richard Lowsby, Jonathan Walker   +3 more
openalex   +1 more source

SGLT2 inhibitor therapy and lower incidence of iron deficiency anaemia in patients with type 2 diabetes: A retrospective cohort study from Germany

Diabetes, Obesity and Metabolism, Volume 27, Issue 11, Page 6559-6566, November 2025.
Abstract Aims Iron deficiency anaemia (IDA) is a common comorbidity in patients with type 2 diabetes mellitus (T2DM). Sodium–glucose cotransporter‐2 inhibitors (SGLT2i) have been shown to modulate erythropoiesis and iron metabolism, but their association remains unclear.
Theresia Sarabhai, Karel Kostev
wiley   +1 more source

Nicorandil in preventing contrast-induced nephropathy in patients undergoing cardiac catheterization procedures: a systematic review and meta-analysis. [PDF]

Ann Med Surg (Lond)
Waseem R, Kumar A, Kumari S, Kumar S, Bai D, Kumar G, Jabbar M, Ashraf T, Nancy F, Mariam B, Dev S, Turesh M, Yousuf MH, Ejaz U, Jawad S.   +14 more
europepmc   +1 more source

Association between admission fasting plasma glucose and contrast-induced nephropathy in elderly acute myocardial infarction patients undergoing percutaneous coronary intervention [PDF]

, 2011
Y. Shiwei, Z. Yujie, Xiaomin Nie, L. Yuyang, Dayi Hu, Wang Jianlong, G. Yonghe, Qing Yuan   +7 more
openalex   +1 more source

Albuminuria is associated with increased risk of dementia, independent of eGFR: The SCREAM project

Journal of Internal Medicine, Volume 298, Issue 5, Page 489-503, November 2025.
Abstract Background The association between albuminuria and dementia has been insufficiently studied, possibly due to not considering dementia subtypes, the interplay with estimated glomerular filtration rate (eGFR), and the use of varying albuminuria measurement techniques.
Li Luo, Ron T. Gansevoort, Lyanne M. Kieneker, Yuanhang Yang, Alessandro Bosi, Rudolf A. de Boer, Casper F. M. Franssen, Maria Eriksdotter, Juan‐Jesus Carrero, Hong Xu   +9 more
wiley   +1 more source

Contrast-Induced Nephropathy (CIN) After Invasive Treatment of Acute Coronary Syndromes-Predictors, Short and Long-Term Outcome. [PDF]

J Clin Med
Sielski J, Kaziród-Wolski K, Piotrowska AM, Jurczak B, Klasa A, Kozieł K, Ludew M, Maj F, Merchel L, Pytlak K, Zabojszcz M, Siudak Z.   +11 more
europepmc   +1 more source

Prevention of Contrast-induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention. [PDF]

Curr Cardiol Rev, 2023
Pranata R, Wahyudi DP.
europepmc   +1 more source